V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20206898 | 20077381 | 1.82 | 48.6 | Palliative (P) | 2016-10-21 | 2016-10-26 | Cisplatin +Fluorouracil (3 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100415094 |
| 20206901 | 20077382 | null | 98 | null | 2019-05-22 | 2019-05-22 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101156283 |
| 20206902 | 20077383 | 1.77 | 79.2 | Neo-adjuvant (N) | 2020-11-26 | 2020-12-10 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100705579 |
| 20206904 | 20077384 | null | null | Neo-adjuvant (N) | null | 2017-12-27 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101262019 |
| 20206905 | 20077385 | 1.74 | 46.9 | Palliative (P) | null | 2018-04-17 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101640400 |
| 20206908 | 20077386 | 1.68 | 62.7 | Curative (C) | 2019-12-09 | 2019-12-23 | Cisplatin +Fluorouracil (2 wk) | 02 | N | CISPLATIN + FLUOROURACIL | 100052941 |
| 20206910 | 20077387 | 1.9 | 94.6 | null | 2019-05-05 | 2019-05-05 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100263963 |
| 20206912 | 20077388 | 1.71 | 64.2 | Palliative (P) | 2017-06-14 | 2017-06-14 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100071202 |
| 20206913 | 20077389 | 0 | 0 | Neo-adjuvant (N) | 2019-06-07 | 2019-07-04 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101130383 |
| 20206915 | 20077390 | 1.55 | 50 | null | 2018-03-18 | 2018-03-25 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 100111952 |
| 20206918 | 20077391 | null | null | Curative (C) | null | 2018-03-20 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100970180 |
| 20206919 | 20077392 | 1.48 | 80.65 | Curative (C) | 2017-11-29 | 2018-01-07 | Capecitabine (21days) + Carboplatin | 02 | Y | CAPECITABINE + CARBOPLATIN | 101809807 |
| 20206926 | 20077393 | 1.64 | 110.7 | Palliative (P) | 2017-10-15 | 2017-10-18 | Capecitabine (21days) + Carboplatin | 02 | N | TRIAL UNSPECIFIED | 101258402 |
| 20206927 | 20077394 | 1.74 | 94.8 | Palliative (P) | 2017-08-07 | 2017-08-28 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101034028 |
| 20206931 | 20077395 | 0 | 0 | Palliative (P) | 2016-05-20 | 2016-06-24 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 101394006 |
| 20206934 | 20077396 | 1.76 | null | Palliative (P) | 2019-06-13 | 2019-07-01 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101667554 |
| 20206935 | 20077397 | 1.8 | 85.9 | null | 2017-06-25 | 2017-07-05 | Capecitabine (21days) + Carboplatin | 02 | null | CISPLATIN + FLUOROURACIL | 100912190 |
| 20206937 | 20077398 | 0 | 0 | 03 | 2018-02-24 | 2018-02-24 | CAPECITABINE + CARBOPLATIN | 02 | N | DOXORUBICIN EMBOLISATION | 100975003 |
| 20206939 | 20077399 | 1.76 | 79.8 | Palliative (P) | 2017-01-03 | 2017-02-22 | CISPLATIN + FLUOROURACIL + RT | 02 | N | CISPLATIN + FLUOROURACIL | 100881372 |
| 20206941 | 20077400 | 1.7 | 65.75 | Neo-adjuvant (N) | 2018-07-12 | 2018-07-15 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101638197 |
| 20206942 | 20077401 | 0 | 0 | Adjuvant (A) | 2019-03-28 | 2019-03-31 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100263295 |
| 20206943 | 20077402 | 1.76 | 52.4 | Palliative (P) | 2019-04-14 | 2019-04-15 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100092967 |
| 20206949 | 20077403 | 1.71 | 85 | Neo-adjuvant (N) | 2021-03-02 | 2021-03-09 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101766256 |
| 20206950 | 20077404 | 1.72 | 87.8 | Palliative (P) | 2017-08-01 | 2017-08-22 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 101251474 |
| 20206956 | 20077405 | 0 | 99 | 03 | 2020-06-05 | 2020-07-05 | Trial Unspecified | 02 | null | TRIAL UNSPECIFIED | 100368518 |
| 20206961 | 20077406 | 1.78 | 65.4 | Neo-adjuvant (N) | 2016-09-05 | 2016-09-19 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100010414 |
| 20206962 | 20077407 | 1.71 | 62.8 | Palliative (P) | 2018-02-07 | 2018-02-18 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100648270 |
| 20206963 | 20077408 | 1.54 | 87.9 | Palliative (P) | 2018-08-10 | 2018-08-23 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101786598 |
| 20206966 | 20077409 | 1.6 | 56.4 | Palliative (P) | 2019-02-24 | 2019-03-13 | CAPECITABINE + CARBOPLATIN | 2 | N | CAPECITABINE + CARBOPLATIN | 100343657 |
| 20206969 | 20077410 | null | null | null | 2019-02-05 | 2019-03-13 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 101186586 |
| 20206976 | 20077411 | 1.74 | 94.2 | null | 2018-05-16 | 2018-05-26 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100403743 |
| 20206977 | 20077412 | 0 | 0 | null | 2016-09-04 | 2016-10-01 | Doxorubicin chemoembolisation | 02 | null | DOXORUBICIN EMBOLISATION | 100667408 |
| 20206979 | 20077413 | 1.8 | 83.1 | Palliative (P) | 2017-09-29 | 2017-10-06 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100716496 |
| 20206981 | 20077414 | 1.62 | 70 | Palliative (P) | 2017-05-22 | 2017-05-24 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100252270 |
| 20206987 | 20077415 | 1.75 | 73.65 | Curative (C) | 2016-04-09 | 2016-04-10 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100334453 |
| 20206988 | 20077416 | null | null | Palliative (P) | 2019-01-18 | 2019-02-15 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100584439 |
| 20206995 | 20077417 | 1.69 | 54.6 | Curative (C) | 2018-08-29 | 2018-09-05 | Cisplatin + Fluorouracil + RT 5day | 02 | Y | CISPLATIN + FLUOROURACIL | 101076404 |
| 20207000 | 20077418 | 1.6 | 84.8 | Neo-adjuvant (N) | 2017-03-01 | 2017-03-01 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101405562 |
| 20207001 | 20077419 | 0 | 0 | Palliative (P) | 2020-12-13 | 2021-02-07 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100910938 |
| 20207002 | 20077420 | 1.65 | 48.4 | Palliative (P) | 2020-03-02 | 2020-03-29 | Doxorubicin chemoembolisation | 02 | N | DOXORUBICIN EMBOLISATION | 100454304 |
| 20207003 | 20077421 | 1.79 | 107.7 | Neo-adjuvant (N) | 2016-09-02 | 2016-09-30 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101705889 |
| 20207008 | 20077422 | 1.78 | 65.4 | Palliative (P) | 2018-08-18 | 2018-08-24 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100692201 |
| 20207013 | 20077423 | 1.79 | 76.2 | Palliative (P) | null | 2018-12-24 | Trial Unspecified | 01 | Y | TRIAL UNSPECIFIED | 101318951 |
| 20207020 | 20077424 | 1.78 | 97.9 | Neo-adjuvant (N) | 2017-07-20 | 2017-08-03 | Capecitabine (21days) + Carboplatin | N | N | TRIAL UNSPECIFIED | 101541859 |
| 20207023 | 20077425 | 1.67 | 66.4 | Neo-adjuvant (N) | 2019-11-05 | 2019-11-05 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100517432 |
| 20207031 | 20077426 | 1.54 | 68 | Curative (C) | 2017-01-19 | 2017-02-27 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100027291 |
| 20207033 | 20077427 | 1.8 | 64.4 | Palliative (P) | null | 2018-11-16 | Doxorubicin chemoembolisation | null | N | DOXORUBICIN EMBOLISATION | 101529144 |
| 20207034 | 20077428 | 1.78 | 71 | Neo-adjuvant (N) | 2016-07-17 | 2016-07-20 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100822933 |
| 20207039 | 20077429 | 1.55 | 94.35 | Palliative (P) | null | 2020-04-16 | Doxorubicin chemoembolisation | 99 | N | DOXORUBICIN EMBOLISATION | 100744913 |
| 20207042 | 20077430 | 1.68 | 70 | Palliative (P) | 2018-12-07 | 2018-12-07 | CAPECITABINE + CARBOPLATIN | N | N | TRIAL UNSPECIFIED | 101061821 |